Shares of Merck and Moderna jumped Tuesday after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots fared well in a small study.
Merck, Moderna detail potential skin cancer vaccine progress

Corporate businessmen working on tablet at office
Comments